Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PSDV - pSivida Limited -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (324)	11/19/2010 4:59:09 PM
From: John McCarthy	Respond to of 421

Hi Arthur << the $5.00 level I picked up a few shares >> thats great ..... Your smarter than me but I thought the FDA thingie was to be on Dec 29th .... (hate it when they do it that late in the year) I agree with phar??? (yahoo) that the price will drift UP to the > $6.00-$7.00 range as we get close to D-DAY. I am somewhat worried about the <<cataract formation>> not so much as an FDA show-stopper but as a sales mo-mo show-slower-downer. But I don't know anything about cataract in general so I feel dumb in evaluating the issue. regards John

To: Arthur Radley who wrote (324)	11/19/2010 5:32:51 PM
From: John McCarthy	Read Replies (1) \| Respond to of 421

Hi Arthur (2nd reply) pharout912 (JUST) posted this on yahoo ..... The deadline for an advisory committee has passed ( 6 weeks prior to prioirty review date). This is a key event because the FDA typically uses a panel if there is a significant question about an NDA. I ( my opinion) is that this is a seminal event and increases the chances of approval significantly. I will discuss more tomorrow about my logic. Going to put a few bottles of champagne away.. we are closer than you think. As far as the label goes please note that the FDA has a good model to work with in the Retisert (for uveitis) is the same drug in a similiar system....more over the weekend but great catch ..... messages.finance.yahoo.com